Bank of Montreal’s Intercept Pharmaceuticals, Inc. ICPT Stock Holding History

Bank of Montreal’s Portfolio ICPT Stock Details ICPT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-11,590	Closed	-$182K	–	4402
2023 Q1	$182K	Buy	+11,590	New	+$201K	﹤0.01%	3061
2022 Q3	–	Sell	-23,135	Closed	-$315	–	4511
2022 Q2	$315	Buy	+23,135	New	+$370K	﹤0.01%	2987
2021 Q4	–	Sell	-61,455	Closed	-$959K	–	3967
2021 Q3	$959K	Sell	61,455 -6,862	-10%	-$110K	﹤0.01%	2524
2021 Q2	$1.46M	Buy	68,317 +60,880	+819%	+$1.21M	﹤0.01%	2247
2021 Q1	$173K	Sell	7,437 -2,900	-28%	-$80.8K	﹤0.01%	3177
2020 Q4	$324K	Sell	10,337 -6,899	-40%	-$229K	﹤0.01%	2949
2020 Q3	$697K	Buy	17,236 +3,429	+25%	+$158K	﹤0.01%	2157
2020 Q2	$605K	Sell	13,807 -3,203	-19%	-$247K	﹤0.01%	2171
2020 Q1	$1.02M	Buy	17,010 +4,394	+35%	+$395K	﹤0.01%	1689
2019 Q4	$1.56M	Sell	12,616 -5,082	-29%	-$455K	﹤0.01%	2010
2019 Q3	$1.18M	Buy	17,698 +638	+4%	+$42.8K	﹤0.01%	1995
2019 Q2	$1.36M	Buy	17,060 +2,447	+17%	+$219K	﹤0.01%	1922
2019 Q1	$1.64M	Buy	14,613 +373	+3%	+$40.8K	﹤0.01%	1789
2018 Q4	$1.44M	Buy	14,240 +1,877	+15%	+$195K	﹤0.01%	1697
2018 Q3	$1.56M	Buy	12,363 +1,385	+13%	+$147K	﹤0.01%	1800
2018 Q2	$921K	Sell	10,978 -5,385	-33%	-$394K	﹤0.01%	2051
2018 Q1	$1.01M	Sell	16,363 -2,710	-14%	-$163K	﹤0.01%	1914
2017 Q4	$1.11M	Buy	19,073 +2,603	+16%	+$164K	﹤0.01%	1902
2017 Q3	$956K	Sell	16,470 -8,362	-34%	-$901K	﹤0.01%	1997
2017 Q2	$3.01M	Sell	24,832 -145	-0.6%	-$16.8K	﹤0.01%	1422
2017 Q1	$2.82M	Buy	24,977 +13,606	+120%	+$1.59M	﹤0.01%	1342
2016 Q4	$1.15M	Sell	11,371 -75	-0.7%	-$8.94K	﹤0.01%	1839
2016 Q3	$1.88M	Buy	11,446 +12	+0.1%	+$1.89K	﹤0.01%	1528
2016 Q2	$1.63M	Buy	11,434 +10,972	+2,375%	+$1.6M	﹤0.01%	1601
2016 Q1	$59K	Sell	462 -93	-17%	-$11K	﹤0.01%	2995
2015 Q4	$83K	Sell	555 -239	-30%	-$40.5K	﹤0.01%	2848
2015 Q3	$132K	Sell	794 -2,972	-79%	-$654K	﹤0.01%	2474
2015 Q2	$909K	Buy	3,766 +2,077	+123%	+$553K	﹤0.01%	1705
2015 Q1	$476K	Buy	1,689 +802	+90%	+$174K	﹤0.01%	1961
2014 Q4	$139K	Buy	887 +416	+88%	+$76.8K	﹤0.01%	2627
2014 Q3	$112K	Sell	471 -124	-21%	-$31.6K	﹤0.01%	2776
2014 Q2	$141K	Sell	595 -1,080	-64%	-$285K	﹤0.01%	2670
2014 Q1	$553K	Buy	+1,675	New	+$565K	﹤0.01%	2004

Other funds holding ICPT

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Caligan Partners New York $1.5B AUM 518.95% 1-Year Est. Return

Citigroup New York $303B AUM 53.02% 1-Year Est. Return

PAMS

Pictet Asset Management (Switzerland) Geneva 73, Switzerland $84.3B AUM 26.5% 1-Year Est. Return

BFM

Boothbay Fund Management New York $7.71B AUM 106.29% 1-Year Est. Return

DCM

DG Capital Management New York $326M AUM 39.67% 1-Year Est. Return

Bank of Montreal's ICPT Position: Q2 2023 in Review

Bank of Montreal sold out of Intercept Pharmaceuticals, Inc. (ICPT) in Q2 2023, closing a stake of 11,590 shares — an estimated $182K sold.

Bank of Montreal first reported a position in ICPT in Q1 2014 and held it in 33 quarters. The position peaked at $3.01M in Q2 2017. 126 funds tracked by Wall St. Rank hold ICPT as of Q2 2023.

Bank of Montreal reported no remaining Intercept Pharmaceuticals, Inc. position as of Q2 2023 after selling out during the quarter.
Bank of Montreal sold 11,590 Intercept Pharmaceuticals, Inc. shares in Q2 2023, an estimated $182K.
Bank of Montreal first reported a position in Intercept Pharmaceuticals, Inc. in Q1 2014 and held it in 33 quarters.
Bank of Montreal's Intercept Pharmaceuticals, Inc. position peaked at $3.01M in Q2 2017.
126 funds tracked by Wall St. Rank held Intercept Pharmaceuticals, Inc. as of Q2 2023.

Based on Bank of Montreal's 13F filing for Q2 2023, filed 2 Aug 2023.